PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed May 14, 2026 · 10-Q · 44 days after period end · 0001140361-26-021286
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$7.35M | -$8.49M | -$10.60M | -$9.66M |
| EPS Diluted | -$0.13 | -$0.21 | -$0.30 | -$0.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 14, 2026 · 44 d after period end
